|
281 |
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes
Enthalten in Cardiovascular diabetology Bd. 16, 10.2.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
282 |
Dreifachkombination fördert Compliance
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 7.2.2017, Nr. 2, date:2.2017: 71
|
|
|
|
283 |
Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study
Enthalten in Drugs & aging Bd. 35, 8.12.2017, Nr. 1, date:1.2018: 73-81
|
|
|
|
284 |
Duloxetine meta-analysis considering benefits and harms
Enthalten in Reactions weekly Bd. 1629, 26.11.2016, Nr. 1, date:11.2016: 7
|
|
|
|
285 |
Dupilumab Use in Atopic Conditions and Its Side Effects
Enthalten in Current dermatology reports Bd. 6, 22.4.2017, Nr. 2, date:6.2017: 43-47
|
|
|
|
286 |
Dysbalance ausgleichen
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 26.9.2017, Nr. 16, date:9.2017: 71
|
|
|
|
287 |
Editorial
Enthalten in Ethik in der Medizin Bd. 10, 1.11.1998, Nr. 4, date:11.1998: 205
|
|
|
|
288 |
Editorial
Enthalten in Ethik in der Medizin Bd. 10, 1.6.1998, Nr. 2, date:6.1998: 63
|
|
|
|
289 |
Effect sizes in ongoing randomized controlled critical care trials
Enthalten in Critical care Bd. 21, 5.6.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
290 |
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
Enthalten in BMC neurology Bd. 17, 10.1.2017, Nr. 1, date:12.2017: 1-11
|
|
Administration
